Shenzhen Zongsheng Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Zongsheng Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ORINYXA. The owner is based in Shenzhen.

No. 3136J, 31st Floor, Daqing Building, 6027 Shennan Avenue

Tian'an Community, Shatou Street, Futian District

Shenzhen 518040 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ORINYXA
ORINYXA
Registered 2025

Trademark Classifications

Shenzhen Zongsheng Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Shenzhen Zongsheng Trading Co., Ltd. have?

Shenzhen Zongsheng Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Zongsheng Trading Co., Ltd. file in?

Shenzhen Zongsheng Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Shenzhen Zongsheng Trading Co., Ltd.'s most well-known trademarks?

Shenzhen Zongsheng Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as ORINYXA. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Zongsheng Trading Co., Ltd.'s trademark registration success rate?

Shenzhen Zongsheng Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.